1. A low-temperature joining technology suitable for high-temperature applications developed by establishing chemical potential and supercooling gradients. (December 2022) Authors: Yang, Jia; Zhao, Wanqi; Lin, Panpan; Zhang, Qiuguang; Zhang, Xinfei; Liu, Weihang; Lin, Tiesong; Peng, He; Zhuang, Yanli Journal: Materials & design Issue: Volume 224(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis. Issue 9 (25th August 2016) Authors: Rovin, Brad H.; van Vollenhoven, Ronald F.; Aranow, Cynthia; Wagner, Carrie; Gordon, Robert; Zhuang, Yanli; Belkowski, Stanley; Hsu, Benjamin Journal: Arthritis & rheumatology Issue: Volume 68:Issue 9(2016) Page Start: 2174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Efficacy and Safety of Treatment With Sirukumab (CNTO 136) in Patients With Active Lupus Nephritis. Issue 9 (September 2016) Authors: Rovin, Brad H.; van Vollenhoven, Ronald F.; Aranow, Cynthia; Wagner, Carrie; Gordon, Robert; Zhuang, Yanli; Belkowski, Stanley; Hsu, Benjamin Journal: Arthritis & rheumatology Issue: Volume 68:Issue 9(2016) Page Start: 2174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomised phase II study evaluating the efficacy and safety of subcutaneously administered ustekinumab and guselkumab in patients with active rheumatoid arthritis despite treatment with methotrexate. Issue 5 (13th January 2017) Authors: Smolen, Josef S; Agarwal, Sandeep K; Ilivanova, Elena; Xu, Xie Lillian; Miao, Ye; Zhuang, Yanli; Nnane, Ivo; Radziszewski, Waldemar; Greenspan, Andrew; Beutler, Anna; Baker, Daniel Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 5(2017) Page Start: 831 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Confirmatory Population Pharmacokinetic Analysis for Sirukumab, a Human Monoclonal Antibody Targeting Interleukin‐6, in Patients With Moderately to Severely Active Rheumatoid Arthritis. (26th March 2018) Authors: Xu, Yan; Hu, Chuanpu; Zhuang, Yanli; Hsu, Benjamin; Xu, Zhenhua; Zhou, Honghui Journal: Journal of clinical pharmacology Issue: Volume 58:Number 7(2018) Page Start: 939 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dew variability in three habitats of a sand dune transect in a desert oasis ecotone, Northwestern China. Issue 3 (14th January 2013) Authors: Zhuang, Yanli; Zhao, Wenzhi Journal: Hydrological processes Issue: Volume 28:Issue 3(2014:Jan.) Page Start: 1399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study. Issue 10136 (2nd June 2018) Authors: Deodhar, Atul; Gottlieb, Alice B; Boehncke, Wolf-Henning; Dong, Bin; Wang, Yuhua; Zhuang, Yanli; Barchuk, William; Xu, Xie L; Hsia, Elizabeth C Journal: Lancet Issue: Volume 391:Issue 10136(2018) Page Start: 2213 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and Safety of Guselkumab, an Interleukin‐23p19–Specific Monoclonal Antibody, Through One Year in Biologic‐Naive Patients With Psoriatic Arthritis. Issue 4 (17th March 2021) Authors: McInnes, Iain B.; Rahman, Proton; Gottlieb, Alice B.; Hsia, Elizabeth C.; Kollmeier, Alexa P.; Chakravarty, Soumya D.; Xu, Xie L.; Subramanian, Ramanand A.; Agarwal, Prasheen; Sheng, Shihong; Jiang, Yusang; Zhou, Bei; Zhuang, Yanli; van der Heijde, Désirée; Mease, Philip J. Journal: Arthritis & rheumatology Issue: Volume 73:Issue 4(2021) Page Start: 604 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of monotherapy with sirukumab compared with adalimumab monotherapy in biologic-naïve patients with active rheumatoid arthritis (SIRROUND-H): a randomised, double-blind, parallel-group, multinational, 52-week, phase 3 study. Issue 5 (26th February 2018) Authors: Taylor, Peter C; Schiff, Michael H; Wang, Qingmin; Jiang, Yusang; Zhuang, Yanli; Kurrasch, Regina; Daga, Shruti; Rao, Ravi; Tak, Paul P; Hsu, Benjamin Journal: Annals of the rheumatic diseases Issue: Volume 77:Issue 5(2018) Page Start: 658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety results from a Phase 3, randomized, placebo‐controlled trial of subcutaneous golimumab in Chinese patients with active rheumatoid arthritis despite methotrexate therapy. (11th August 2015) Authors: Li, Zhanguo; Zhang, Fengchun; Kay, Jonathan; Fei, Kaiyin; Han, Chenglong; Zhuang, Yanli; Wu, Zhong; Hsia, Elizabeth C. Journal: International journal of rheumatic diseases Issue: Volume 19:Number 11(2016) Page Start: 1143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗